Intensive fibrosarcoma-binding capability of the reconstituted analog and its antitumor activity
Jian Xu(University of California, Los Angeles), Yong‐Su Zhen(Chinese Academy of Medical Sciences & Peking Union Medical College), Chuan-Kun Shan(Chinese Academy of Medical Sciences & Peking Union Medical College), Yue Du(Shandong University of Technology), Guimin Xia(Chinese Academy of Medical Sciences & Peking Union Medical College), Liang Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Liang Li(Shanghai Public Health Clinical Center), Wenjuan Liu(Shandong University), Xiujun Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiaofei Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Hongfei Yi(Sichuan University)
Cited by 6
Related Papers
HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer
|Gastric Cancer|2014|615
Circulating MicroRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis
|Molecular Carcinogenesis|2010|558
Drug resistance to targeted therapeutic strategies in non-small cell lung cancer
|Pharmacology & Therapeutics|2019|245
Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations
|Nature Genetics|2011|198
Nanoparticle Systems for Cancer Vaccine
|Nanomedicine|2019|145